Description
Indications and Usage
Rapid restore muscle tissue atrophied during recovery from a traumatic injury. Offset muscle catabolism in patients with a wasting syndrome. Treat certain types of anemia which are non-responsive to first line agents.
Contraindication
The use of Oxybolic contraindicated in the following: Not indicated for women, children, or the elderly. Patient with diagnosed or suspected male breast carcinoma or carcinoma of the prostate. Patient with diagnosed or suspected female breast carcinoma with hypercalcemia as androgenic agents may increase osteolytic bone resorption. Women who are pregnant or may become pregnant because of possible masculinisation of the fetus. Patient with hypercalcemia. Patient with pre existing cardiac, renal, and/or hepatic disease. This product is hepatotoxic and requires hepatic monitoring discontinue if jaundicing presents.
Drug Interactions
Oral hypoglycaemic agents: may inhibit the metabolism of oral hypoglycaemic agents which may require adjustments of dosage.
Anticoagulants
Patients on anticoagulants should be carefully monitored during anabolic steroid therapy as anabolic steroids may increase sensitivity to oral anticoagulants. Patients should be monitored regularly during anabolic steroid therapy, particularly during initiation and termination of therapy.
Side Effects/Adverse Reactions
Men: Preupbertal: phallic enlargement, increased frequency of erections. Postpubertal: inhibition of testicular function, oligospermia, gynecomastia.
Women: Hirsutism: male pattern baldness; deepening of voice; clitoral enlargement. These changes are usually irreversible even after prompt discontinue of therapy and are not prevented by concomitant use of estrogens. In addition, the following may occur: menstrual irregularities; masculinisation of the fetus.
Reviews
There are no reviews yet.